ICUCW SeaStar Medical Holding Corporation - Warrant
$0,02
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 12, 2026
52 Haftlık Aralık
$0–$0
56% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
—
ROE
-176.6%
Net Kâr Marjı
-984.6%
ICUCW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.02
Piyasa Değeri
—
P/E (TTM)
—
EPS (TTM)
$-6.63
Gelir (TTM)
$1M
Temettü Verimi
—
ROE
-176.6%
D/E Borç/Özsermaye
0.1
52 Haftlık Aralık
$0 – $0
ICUCW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$1M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-6.63
2021-12-31
→
2024-12-31
Serbest Nakit Akışı
—
Marjlar
-984.6%
2025-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ICUCW
Akran Ortalaması
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ICUCW
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
95.7%
—
Operating Margin (Faaliyet Kâr Marjı)
-986.6%
—
Net Profit Margin (Net Kâr Marjı)
-984.6%
—
ROA
-129.2%
—
ROE
-176.6%
—
ROIC
-111.3%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ICUCW
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.1
—
Current Ratio (Cari Oran)
3.6
—
Quick Ratio (Cari Oran)
3.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ICUCW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
814.1%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ICUCW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $1M | $135.0K | $0 | |
| Cost of Revenue | $53.0K | $0 | $0 | |
| Gross Profit | $1M | $135.0K | $0 | |
| R&D Expense | $8M | $9M | $6M | |
| SG&A Expense | $6M | $9M | $8M | |
| Operating Expenses | $13M | $18M | $14M | |
| Operating Income | $-12M | $-18M | $-14M | |
| Interest Expense | · | $244.0K | $1M | |
| Interest Income | $325.0K | $101.0K | $0 | |
| Other Non-op | $28.0K | $-7M | $-12M | |
| Pretax Income | $-12M | $-25M | $-26M | |
| Income Tax | $3.0K | $3.0K | $0 | |
| Net Income | $-12M | $-25M | $-26M | |
| EPS (Basic) | $-5.86 | $-66.33 | $-30.26 | |
| EPS (Diluted) | · | $-6.63 | $-30.26 | |
| Shares (Basic) | 2,073,087 | 374,356 | 866,813 | |
| Shares (Diluted) | · | 3,743,554 | 866,813 | |
| EBITDA | $-12M | · | · |
Bilanço 20
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $12M | $2M | $176.0K | |
| Receivables | $237.0K | $112.0K | $0 | |
| Inventory | $66.0K | $0 | · | |
| Prepaid Expense | $1M | $2M | $2M | |
| Current Assets | $14M | $4M | $2M | |
| Other Non-current Assets | $578.0K | $892.0K | · | |
| Total Assets | $14M | $5M | $4M | |
| Accounts Payable | $948.0K | $3M | $4M | |
| Accrued Liabilities | $2M | $3M | $2M | |
| Short-term Debt | $525.0K | $574.0K | $565.0K | |
| Current Liabilities | $4M | $7M | $13M | |
| Total Liabilities | $4M | $7M | $17M | |
| Long-term Debt | · | · | $4M | |
| Total Debt | $525.0K | · | · | |
| Common Stock | $4.0K | $2.0K | $1.0K | |
| Paid-in Capital | $162M | $137M | $101M | |
| Retained Earnings | $-152M | $-140M | $-115M | |
| Stockholders' Equity | $10M | $-2M | $-14M | |
| Liabilities + Equity | $14M | $5M | $4M | |
| Shares Outstanding | 3,844,613 | 650,639 | 2,016,045 |
Nakit Akışı 7
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $624.0K | $887.0K | $2M | |
| Operating Cash Flow | $-14M | $-16M | $-10M | |
| Debt Issued | · | $1M | · | |
| Stock Issued | $16M | $17M | $5M | |
| Net Stock Activity | $16M | · | · | |
| Financing Cash Flow | $24M | $18M | $10M | |
| Net Change in Cash | $10M | $2M | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 95.7% | · | · | |
| Operating Margin | -986.6% | · | · | |
| Net Margin | -984.6% | · | · | |
| Pretax Margin | -984.4% | · | · | |
| EBITDA Margin | -986.6% | · | · | |
| ROA | -129.2% | · | · | |
| ROE | -176.6% | · | · | |
| ROIC | -111.3% | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 3.6 | · | · | |
| Quick Ratio | 3.3 | · | · | |
| Debt / Equity | 0.1 | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | |
| Inventory Turnover | 1.6 | · | · | |
| Receivables Turnover | 7.1 | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 814.1% | · | · |
Değerleme (TTM) 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $1M | $135.0K | $0 | |
| Net Income TTM | $-12M | $-25M | $-26M |
Gelir Tablosu 18
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $615.0K | $420.0K | $183.0K | $338.0K | $293.0K | $67.0K | $68.0K | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $54.0K | $12.0K | $14.0K | $27.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Gross Profit | $561.0K | $408.0K | $169.0K | $311.0K | $293.0K | $67.0K | $68.0K | $0 | $0 | · | · | |
| R&D Expense | $3M | $2M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $2M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $3M | $4M | $2M | $4M | $5M | $5M | $5M | $4M | $3M | $3M | |
| Operating Income | $-4M | $-3M | $-4M | $-2M | $-4M | $-5M | $-4M | $-5M | $-4M | $-3M | $-3M | |
| Interest Expense | · | · | · | $9.0K | $11.0K | · | $272.0K | $82.0K | $143.0K | $199.0K | $224.0K | |
| Interest Income | $69.0K | $125.0K | $107.0K | $45.0K | $48.0K | $18.0K | $58.0K | $25.0K | $0 | $0 | $0 | |
| Other Non-op | $61.0K | $114.0K | $107.0K | $-246.0K | $53.0K | $348.0K | $-22.0K | $1M | $-9M | $-7M | $-4M | |
| Pretax Income | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-3M | $-13M | $-9M | $-7M | |
| Income Tax | $0 | $0 | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $0 | $-5.0K | $0 | |
| Net Income | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-3M | $-13M | $-9M | $-7M | |
| EPS (Basic) | $-0.91 | $-5.11 | $-0.13 | $-1.77 | $-0.44 | $-59.47 | $-1.10 | $-1.03 | $-4.73 | $-16.60 | $-9.02 | |
| EPS (Diluted) | · | · | · | $-0.18 | $-0.44 | · | $-1.10 | $-1.03 | $-4.73 | $-16.60 | $-9.02 | |
| Shares (Basic) | 4,084,283 | -44,267,762 | 26,393,400 | 1,132,952 | 8,617,932 | -9,551,540 | 4,086,871 | 3,154,782 | 2,684,243 | -13,558,293 | 801,939 | |
| Shares (Diluted) | · | · | · | 11,329,517 | 8,617,932 | · | 4,086,871 | 3,154,782 | 2,684,243 | -13,558,293 | 801,939 | |
| EBITDA | $-4M | · | $-4M | $-2M | $-4M | · | $-4M | $-5M | $-4M | · | $-3M |
Bilanço 20
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $12M | $14M | $6M | $5M | $2M | $2M | $1M | $5M | $176.0K | $73.0K | |
| Receivables | $208.0K | $237.0K | $221.0K | $217.0K | $110.0K | $112.0K | $68.0K | · | · | $0 | · | |
| Inventory | $77.0K | $66.0K | $83.0K | $77.0K | $44.0K | $0 | $0 | · | · | · | · | |
| Prepaid Expense | $984.0K | $1M | $807.0K | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | |
| Current Assets | $8M | $14M | $15M | $8M | $7M | $4M | $4M | $2M | $7M | $2M | $2M | |
| Other Non-current Assets | $421.0K | $578.0K | $656.0K | · | · | $892.0K | · | · | · | · | · | |
| Total Assets | $9M | $14M | $16M | $8M | $8M | $5M | $5M | $3M | $8M | $4M | $2M | |
| Accounts Payable | $750.0K | $948.0K | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | |
| Accrued Liabilities | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | |
| Short-term Debt | $134.0K | $525.0K | $0 | $0 | $363.0K | $574.0K | $0 | $3M | $357.0K | $565.0K | $0 | |
| Current Liabilities | $4M | $4M | $4M | $5M | $7M | $7M | $7M | $10M | $10M | $13M | $12M | |
| Total Liabilities | $4M | $4M | $4M | $5M | $7M | $7M | $7M | $10M | $12M | $17M | $18M | |
| Long-term Debt | · | · | · | · | · | · | $0 | $0 | $1M | $4M | $6M | |
| Total Debt | $134.0K | · | $0 | $0 | $363.0K | · | $0 | $3M | $357.0K | · | $0 | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $8.0K | $1.0K | $3.0K | |
| Paid-in Capital | $163M | $162M | $160M | $149M | $144M | $137M | $133M | $124M | $123M | $101M | $100M | |
| Retained Earnings | $-159M | $-152M | $-149M | $-145M | $-143M | $-140M | $-135M | $-131M | $-127M | $-115M | $-116M | |
| Stockholders' Equity | $4M | $10M | $11M | $3M | $565.0K | $-2M | $-2M | $-7M | $-4M | $-14M | $-16M | |
| Liabilities + Equity | $9M | $14M | $16M | $8M | $8M | $5M | $5M | $3M | $8M | $4M | $2M | |
| Shares Outstanding | 4,259,842 | 3,844,613 | 34,096,420 | 17,343,269 | 9,257,763 | 650,639 | 4,214,399 | 1,904,611 | 75,419,458 | 2,016,045 | 27,201,087 |
Nakit Akışı 8
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $-99.0K | $70.0K | $290.0K | $97.0K | $167.0K | $212.0K | $200.0K | $41.0K | $434.0K | $386.0K | $484.0K | |
| Operating Cash Flow | $-3M | $-4M | $-4M | $-3M | $-3M | $-5M | $-5M | $-3M | $-3M | $-4M | $-1M | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $1M | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $1M | · | · | |
| Stock Issued | $810.0K | $2M | $9M | $4M | $2M | $4M | $9M | $-51.0K | $5M | $3M | $120.0K | |
| Net Stock Activity | · | · | · | · | $2M | · | · | · | $5M | · | · | |
| Financing Cash Flow | $605.0K | $2M | $11M | $4M | $6M | $4M | $6M | $-1M | $8M | $5M | $1M | |
| Net Change in Cash | $-2M | $-2M | $7M | $1M | · | $-263.0K | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 91.2% | · | 92.3% | 92.0% | 100.0% | · | 100.0% | · | · | · | · | |
| Operating Margin | -616.4% | · | -1955.7% | -519.5% | -1304.4% | · | -6552.9% | · | · | · | · | |
| Net Margin | -606.5% | · | -1897.3% | -592.3% | -1287.4% | · | -6585.3% | · | · | · | · | |
| Pretax Margin | -606.5% | · | -1897.3% | -592.3% | -1286.3% | · | -6585.3% | · | · | · | · | |
| EBITDA Margin | -616.4% | · | -1955.7% | -519.5% | -1304.4% | · | -6552.9% | · | · | · | · | |
| ROA | -43.8% | · | -34.5% | -33.8% | -49.2% | · | -131.1% | -111.6% | -228.2% | · | -13.6% | |
| ROE | -97.7% | · | -73.8% | 112.5% | 193.0% | · | 49.9% | 35.3% | 165.4% | · | 59.9% | |
| ROIC | -85.6% | · | -31.2% | -52.6% | -412.2% | · | 217.2% | 124.3% | 96.0% | · | 18.5% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 3.7 | 1.5 | 1.0 | · | 0.5 | 0.2 | 0.7 | · | 0.2 | |
| Quick Ratio | 1.6 | · | 3.4 | 1.3 | 0.8 | · | 0.3 | 0.1 | 0.5 | · | 0.0 | |
| Debt / Equity | 0.0 | · | 0.0 | 0.0 | 0.6 | · | 0.0 | -0.5 | -0.1 | · | 0.0 | |
| Interest Coverage | · | · | · | -195.1 | -347.5 | · | -16.4 | -56.9 | -27.6 | · | -13.1 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.7 | · | 0.3 | 0.7 | 0.0 | · | · | · | · | · | · | |
| Receivables Turnover | 2.9 | · | 1.3 | 3.1 | 5.3 | · | 2.0 | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | · | $882.0K | $699.0K | $361.0K | · | $68.0K | · | · | · | · | |
| Net Income TTM | $-13M | · | $-14M | $-13M | $-24M | · | $-28M | $-26M | $-29M | · | $-19M | |
| Market Cap | $126.9K | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | $-7M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.1 | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 1.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | -4.1 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -9228.2% | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Gelir | $1M | $135.0K | $0 | — | — |
| Brüt Kâr Marjı % | 95.7% | — | — | — | — |
| Faaliyet Kâr Marjı % | -986.6% | — | — | — | — |
| Net Gelir | $-12M | $-25M | $-26M | — | — |
| Seyreltilmiş Hisse Başı Kâr | — | $-6.63 | $-30.26 | — | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | — | — | — | — |
| Cari Oran | 3.6 | — | — | — | — |
| Cari Oran | 3.3 | — | — | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 17 dosya · $921K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 4 (+3 önceki Ç'ye göre) | 0 (-5 önceki Ç'ye göre) | 2 (+2 önceki Ç'ye göre) | 1 (0 önceki Ç'ye göre) | +111K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $899.884 | 245.200 | 97,68% | Hisse senetleri |
| ATW SPAC MANAGEMENT LLC | $6.645 | 245.200 | 0,72% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $3.657 | 211.381 | 0,40% | Hisse senetleri |
| Linden Advisors LP | $3.511 | 218.073 | 0,38% | Hisse senetleri |
| LMR Partners LLP | $2.163 | 125.000 | 0,23% | Hisse senetleri |
| CLEAR STREET LLC | $929 | 46.690 | 0,10% | Hisse senetleri |
| Clear Street Group Inc. | $808 | 46.690 | 0,09% | Hisse senetleri |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $692 | 40.000 | 0,08% | Hisse senetleri |
| EQUITEC PROPRIETARY MARKETS, LLC | $618 | 35.700 | 0,07% | Hisse senetleri |
| Cruiser Capital Advisors, LLC | $562 | 32.473 | 0,06% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $539 | 36.179 | 0,06% | Hisse senetleri |
| TWO SIGMA SECURITIES, LLC | $421 | 24.322 | 0,05% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $389 | 22.500 | 0,04% | Alım opsiyonu |
| StoneX Group Inc. | $208 | 11.086 | 0,02% | Hisse senetleri |
| WOLVERINE ASSET MANAGEMENT LLC | $192 | 11.081 | 0,02% | Hisse senetleri |
| UBS Group AG | $14 | 801 | 0,00% | Hisse senetleri |
| Virtu Financial LLC | $1 | 40.316 | 0,00% | Hisse senetleri |
Şirket yöneticileri 6 içeriden öğrenenler · 2 yöneticiler · 4 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Eric Schlorff | Chief Executive Officer | 01 Temmuz 2026 A | 50.140 | 0 | 0 | $0 |
| Kevin Chung | Chief Medical Officer | 01 Temmuz 2026 A | 28.021 | 0 | 0 | $0 |
| Bernadette N Vincent | Yönetim kurulu üyesi | 01 Temmuz 2026 A | 8.200 | 0 | 0 | $0 |
| Jennifer A Baird | Yönetim kurulu üyesi | 01 Temmuz 2026 A | 10.620 | 0 | 0 | $0 |
| John Neuman | Yönetim kurulu üyesi | 01 Temmuz 2026 A | 16.200 | 0 | 0 | $0 |
| Kenneth Van Heel | Yönetim kurulu üyesi | 01 Temmuz 2026 A | 11.940 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış